Literature DB >> 8835873

Cytokines in myocarditis and cardiomyopathies.

A Matsumori.   

Abstract

Myocarditis is thought to be caused by various viruses, and accumulating evidence links viral myocarditis with the eventual development of dilated cardiomyopathy. Recently the importance of hepatitis C virus infection was noted in patients with dilated cardiomyopathy. Cytokines are increasingly recognized as an important factor in the pathogenesis and pathophysiology of myocarditis and cardiomyopathy. Elevated circulating cytokines have been reported in patients with heart failure, and various cytokines have been shown to depress myocardial contractility in vitro and in vivo. A number of recent studies showed that cytokines generated by activated immune cells cause an increase in NO (nitric oxide) via induction of NO synthase. Increased generation of NO may induce negative inotropism and myocardial damage. This review discusses the etiology and pathogenesis of myocarditis and cardiomyopathy from this point of view.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835873     DOI: 10.1097/00001573-199605000-00011

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  12 in total

Review 1.  [Cytokines and heart diseases. Attempt at an update].

Authors:  K Werdan
Journal:  Med Klin (Munich)       Date:  1997-07-15

2.  IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease.

Authors:  P Skyllouriotis; M Skyllouriotis-Lazarou; S Natter; R Steiner; S Spitzauer; S Kapiotis; P Valent; A M Hirschl; S E Guber; G Laufer; G Wollenek; E Wolner; M Wimmer; R Valenta
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

3.  [Clinical picture and differential diagnosis of cardiomyopathy and myocarditis].

Authors:  H H Sigusch; D Reinhardt; H R Figulla
Journal:  Med Klin (Munich)       Date:  1998-04-15

4.  Calpain inhibition protects against virus-induced apoptotic myocardial injury.

Authors:  R L DeBiasi; C L Edelstein; B Sherry; K L Tyler
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 5.  [Cardiomyopathies. I: classification of cardiomyopathies--dilated cardiomyopathy].

Authors:  H P Schultheiss; M Noutsias; U Kühl; D Lassner; U Gross; W Poller; M Pauschinger
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

6.  Necropsy diagnosis of myocarditis: a retrospective study using CD45RO immunohistochemistry.

Authors:  K M Feeley; J Harris; S K Suvarna
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

Review 7.  Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?

Authors:  M Pauschinger; M Noutsias; D Lassner; H-P Schultheiss; U Kuehl
Journal:  Clin Res Cardiol       Date:  2006-08-16       Impact factor: 5.460

8.  Cetirizine a histamine H1 receptor antagonist improves viral myocarditis.

Authors:  Akira Matsumori; Kanjo Yamamoto; Miho Shimada
Journal:  J Inflamm (Lond)       Date:  2010-08-04       Impact factor: 4.981

9.  HBEGF, SRA1, and IK: Three cosegregating genes as determinants of cardiomyopathy.

Authors:  Frauke Friedrichs; Christian Zugck; Gerd-Jörg Rauch; Boris Ivandic; Dieter Weichenhan; Margit Müller-Bardorff; Benjamin Meder; Nour Eddine El Mokhtari; Vera Regitz-Zagrosek; Roland Hetzer; Arne Schäfer; Stefan Schreiber; Jian Chen; Isaac Neuhaus; Ruiru Ji; Nathan O Siemers; Norbert Frey; Wolfgang Rottbauer; Hugo A Katus; Monika Stoll
Journal:  Genome Res       Date:  2008-12-08       Impact factor: 9.043

10.  Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy.

Authors:  Lun Wang; Yang Zhang; Shuyang Zhang
Journal:  Front Cardiovasc Med       Date:  2020-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.